- Author:
Wongi SEOL
1
;
Hyejung KIM
;
Ilhong SON
Author Information
- Publication Type:종설
- From:Journal of the Korean Neurological Association 2021;39(3):129-133
- CountryRepublic of Korea
- Language:Korean
- Abstract: Since the neuroprotective effects of coffee and tobacco on Parkinson’s disease have been reported more than 50 years ago, clinical studies using caffeine and nicotine that were presumed as effective components of coffee and tobacco, respectively, are being actively executed. However, most results failed to show significant differences between the tested and control groups, and some studies revealed contradictory results to the neuroprotection. The reason for this might be that the effective components are something other than nicotine or caffeine, and/or differences to design the clinical trials such as patients recruiting, prescribed amount and period, and analyzed criteria etc. The review summarizes recent results for effect of coffee, tobacco as well as alcohol, representatives of indulgent food, on Parkinson’s disease.